Sector: Healthcare | Industry: Managed Health Care |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 9900 Bren Rd E HOPKINS MN 55343-9664 |
Tel: | 1-800-3285979 |
Website: | https://www.unitedhealthgroup.com |
IR: | See website |
Key People | ||
Stephen J. Hemsley Non-Executive Chairman of the Board | Dirk C. Mcmahon President, Chief Operating Officer | Andrew Philip Witty Chief Executive Officer, Director |
John F. Rex Chief Financial Officer, Executive Vice President | Brian R. Thompson Chief Executive Officer of UnitedHealthcare | Erin L. Mcsweeney Chief People Officer, Executive Vice President |
Rupert Bondy Executive Vice President, Corporate Secretary, Chief Legal Officer | Thomas E. Roos Senior Vice President, Chief Accounting Officer |
Business Overview |
UnitedHealth Group Incorporated is a diversified health care company that operates Optum and UnitedHealthcare platforms. Its segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. Optum Health segment is focused on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Insight segment serves the needs of hospital systems, physicians, health plans, governments and life sciences companies. Optum Rx segment offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. UnitedHealthcare includes the combined results of operations of UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State and UnitedHealthcare Global. |
Financial Overview |
For the fiscal year ended 31 December 2023, UnitedHealth Group Inc revenues increased 15% to $371.62B. Net income increased 11% to $22.38B. Revenues reflect UnitedHealthCare segment increase of 13% to $281.36B, Optum Health segment increase of 34% to $95.32B, Optum Rx segment increase of 16% to $116.09B. Dividend per share increased from $6.40 to $7.29. Basic Earnings per Share excluding Extraordinary Items increased from $21.47 to $24.12. |
Employees: | 440,000 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $491,716M as of Dec 31, 2023 |
Annual revenue (TTM): | $371,622M as of Dec 31, 2023 |
EBITDA (TTM): | $36,330M as of Dec 31, 2023 |
Net annual income (TTM): | $22,381M as of Dec 31, 2023 |
Free cash flow (TTM): | $18,921M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $37,110M as of Dec 31, 2023 |
Shares outstanding: | 921,934,109 as of Jan 31, 2024 |
Index Membership: | S&P 500, Dow Industry |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |